Atara Biotherapeutics Inc
Biotechnology
Healthcare
ATRA
7.47 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
5.52
52 week high
18.00
high
5.95
52 week low
5.59
low
5.30
growth
-57.99 %
previous Close
5.59
P/E ratio
-2
market cap
65.66 M
div yield
0
usd
Sep 2024
qoq
revenue
40.19 M
40.33 %
net incoming
-21.91 M
-15.01 %
eps
-2.93 %
5.48 %
eps surprise
83.04 %
net profit margin
-54.51 %
0.12 %
operating incoming
-21.76 M
-19.34 %
net change in cash
15.14 M
501.25 %
cash on hand
46.45 M
48.35 %
cost of revenue
7.60 M
64.30 %
top top